School of Medicine
Showing 1-6 of 6 Results
-
Bruna de Freitas Dias
Postdoctoral Scholar, Psychiatry
BioI am a Brazilian physician and neuroscientist with a special interest in autoimmune neurological diseases. I graduated from Albert Einstein Medical School, Sao Paulo – Brazil in 2021. My research predominantly focuses on studying the epidemiology of autoimmune encephalitis and genetic susceptibility to the disease onset. Furthermore, I am interested in assessing the burden of the disease in those patients, socioeconomic analysis, and environmental and infectious triggers for the disease onset. At Mignot’s Lab, I am involved in IGNITE project, and I am working in the association of clinical and epidemiological data, KIR sequencing, and GWAS analysis.
My interests include general neurology, neuroimmunology, neuroscience, healthcare, and technology. -
Chunyang Dong
Postdoctoral Scholar, Psychiatry
BioChunyang Dong completed his Ph.D. studies from University of California, Davis with Dr. Lin Tian, where he specialized in protein engineering to develop genetically encoded biosensors to enable real-time imaging of neuromodulator dynamics. As part of his postdoctoral pursuits with Dr. Sergiu Pasca at Stanford University, he hopes to combine disciplines between biosensors and modeling human neurological disease using brain region-specific organoids. Despite this shift, his unwavering goal is to deepen the understanding of brain development, disease processes, and translate research to potential treatments for neurological disorders.
-
Igor D. Bandeira
Postdoctoral Scholar, Psychiatry
BioIgor D. Bandeira, M.D., Ph.D., is a Postdoctoral Research Fellow in the Department of Psychiatry and Behavioral Sciences at Stanford University. With extensive experience in interventional psychiatry, Dr. Bandeira has led multiple clinical trials focused on advancing treatments for mental disorders across children, adolescents, and adults. He received the prestigious Professor Alfredo Thomé de Britto Award in recognition of his exceptional research achievements during his physician-scientist training at the Federal University of Bahia in Salvador, Brazil.
As part of his medical training, Dr. Bandeira also studied at the University of Sydney (Australia) on a Science Without Borders Scholarship, where he enhanced his clinical and research skills at the university’s Brain and Mind Centre. Upon returning to Brazil, he gained valuable clinical experience as an attending physician with the Brazilian Ministry of Health and worked on the frontlines during the COVID-19 pandemic.
Dr. Bandeira’s research focuses on noninvasive brain stimulation and rapid-acting antidepressants for treatment-resistant depression, bipolar depression, and suicidal behavior. At Stanford, he has further advanced his expertise in clinical trials by leading the Wellcome LEAP trial on accelerated intermittent theta-burst stimulation (Stanford Neuromodulation Therapy) for anhedonic depression and co-leading a trial supported by the American Foundation for Suicide Prevention to evaluate the efficacy and safety of buprenorphine in sustaining the antisuicidal and antidepressant effects of ketamine.
Looking ahead, Dr. Bandeira plans to apply for psychiatry residency programs in the United States to advance his career in academic psychiatry and clinical research.
